
European Journal of Medicinal Chemistry p. 419 - 424 (1990)
Update date:2022-08-04
Topics:
Gatta, F.
Perotti, F.
Gradoni, L.
Gramiccia, M.
Orsini, S.
et al.
A number of 1-(2,3-dihydroxypropyl)- and 1-<2-(1,3-dihydroxypropyl)>pyrazolo<3,4-d>pyrimidines were synthesized.Some of these compounds were evaluated for their activity against Leishmania infantum and Trypanosoma brucei brucei in mice.The highest degree of antileishmanial activity was displayed by the 4-amino-1-(RS)-(2,3-dihydroxypropylpyrazolo<3,4-d>pyrimidine 11a, which yielded a 87percent and 96percent parasite inhibition in a standard 5-day test and in a long-term (14 days) treatment, respectively, though full cures of animals were not achieved.On the contrary, thisderivative did not significantly prolong the survival of T b brucei infected mice.
View Morewebsite:http://www.arromax.com
Contact:+86-0512-62959601 skype:aimmezhang
Address:Suite 401, Bldg A3, 218 Xinghu St.Suzhou Industrial Park 215123, P.R. China
Jewim Pharmaceutical (Shandong) Co., Ltd
Contact:+8615621883869
Address:山东省泰安市高新技术产业开发区配天门大街西首
Jinan Trio PharmaTech Co., Ltd
Contact:86-531-88811783;+(0)13153010282
Address:2766 Yingxiu Road, Jinan High-Tech Zone, China
Dayang Chem (Hangzhou) Co.,Ltd.
website:http://www.dycnchem.com
Contact:+86-571-88938639
Address:9/F, Unit 2 Changdi Torch Building, 259# WenSan Road, Xihu District, Hangzhou City 310012, P.R.China
Doi:10.1021/ja201589k
(2011)Doi:10.1007/s10562-020-03332-7
(2021)Doi:10.1016/S0040-4039(00)97844-4
(1990)Doi:10.1016/S0040-4039(00)97743-8
(1990)Doi:10.1055/s-0030-1258445
(2011)Doi:10.1021/ja203227q
(2011)